Navigation Links
GeoVax Labs' CEO Update Letter to Shareholders
Date:1/9/2012

and the U.S. Military HIV Research Program heralded a preventative vaccine that gave protection in non-human primates, a result similar to what GeoVax published earlier last year. This report confirmed the prime-boost approach plus the use of similar genetic material in the vaccine to induce a protective immune response. In essence, they have validated our concepts and added some good news to the field. Results like this give the industry hope that an effective HIV vaccine is not far from reality and bolster our confidence that we are on the right track.

Financing and Corporate Development

We continue to benefit from tremendous financial, operational, and technical support provided to us by the NIH and the HVTN. The HVTN, funded by the NIH, is the largest worldwide clinical trials network dedicated to development and testing of promising HIV/AIDS vaccines. To date, the HVTN has conducted and funded all of our clinical trials for the preventative version of our vaccine. In addition to this support from the HVTN, we are the recipient of a $20 million Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant from the National Institute of Allergy and Infectious Disease (NIAID). This five-year grant spans a period from September 2007 through August 2012, providing financial support for the development of the GM-CSF adjuvanted version of our preventative vaccine.

While we are deeply appreciative of the generous governmental support we receive, it does not cover the cost of all of our activities. Hence, fundraising will continue to be a primary and critical focus for 2012, as it was in 2011. Through our efforts during 2010 and 2011 we have developed numerous contacts and raised our exposure profile among potential institutional investors which we believe will benefit us going forward. In addition to our equity financing efforts, we will continue to seek out additional opportunities for non-dilutive financing through govern
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
2. GeoVax Phase 2a Clinical Trial Completes Enrollment
3. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
4. GeoVax Labs, Inc. Announces Second Quarter Financial Results
5. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
6. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
7. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
8. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
9. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
10. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11. GeoVax Labs Engages The Investor Relations Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Perrigo Company (NYSE: ... has received an AB therapeutic equivalent rating from the ... approved New Drug Application (NDA) for testosterone gel 1.0%. ... to [AbbVie,s] AndroGel 1% and can be substituted with ... clinical effect and safety profile as AndroGel 1% when ...
(Date:7/24/2014)... 24, 2014 Talyst, a market leader in ... Association of State Veterans Homes (NASVH) Summer Conference in ... of the NASVH is to ensure that each and ... term health care and respect which they have earned ... the InSite® Remote Dispensing System, Talyst can help State ...
(Date:7/24/2014)... Calif. , July 24, 2014  Lazarus ... development of novel interventional devices to facilitate removal ... States Patent and Trademark Office has issued a ... technology behind the company,s Lazarus Cover TM ... The Lazarus ReCover is a single-component stent-retriever (stentriever) ...
Breaking Medicine Technology:Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2
... Results Expected in November 2008, BOTHELL, Wash., Oct. ... today the completion of patient enrollment and dosing,for the ... safety and,efficacy of its formulation of 12-hour extended-release (ER) ... report top-line,results from this pivotal trial in November 2008. ...
... world,s most influential medical journal, the New England Journal,of ... company,s study,of the Diamyd(R) diabetes vaccine for type 1 ... article is now available on the journal,s web site,( ... 30. It presents the,results of the concluded Phase II ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4
(Date:7/25/2014)... July 25, 2014 In an election year ... no surprise that Americans may not be sleeping well, and ... to a new poll conducted by US-Mattress . The ... across the country, “Which Political Party Do You Side With,” ... those registered as Independents tout a higher rate of good ...
(Date:7/25/2014)... NY (PRWEB) July 25, 2014 Ticket ... the Guinness International Champions Cup Match between Manchester City ... New York, one of the most iconic locations is Yankee ... Yankee Stadium, but it is quickly becoming a location that ... facility is home to the New York Yankees from Major ...
(Date:7/25/2014)... Oncology (ESMO), the leading pan-European association representing medical ... EU General Data Protection Regulation [1] could make ... to both doctors and cancer patients. , The ... and specific patient consent, meaning that researchers would ... is planned in order to consult their data ...
(Date:7/25/2014)... July 25, 2014 Yisrayl Hawkins, Pastor and ... article on his blog explaining why so many prayers are ... most. , In the article, Yisrayl gives many examples ... shares the results. For example, in one case, in the ... church grounds to pray for rain; ironically, they received a ...
(Date:7/25/2014)... 2014 iTanSmart is a patented iOS ... app provides a tailored approach to eliminating the guesswork ... and skin damage. In his review, Eaton had positive ... of iTanSmart. , Eaton begins his commentary ... ‘better organized’ and ‘great alternative’ to its related Android ...
Breaking Medicine News(10 mins):Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 2Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 3Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 3Health News:Is Europe putting cancer research at risk? 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 3Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3
... don,t protect against UVA rays, which can cause skin cancer ... of the most popular protections people use as the summer ... harmful ultraviolet rays. , Sunburns are not only painful, they ... cancer in the United States. , But, new research has ...
... WASHINGTON, July 12 Speaker Nancy Pelosi,issued the following statement ... "In his 70 years of medical practice, Dr. DeBakey had ... the globe by literally fixing, broken hearts. We honored ... Medal earlier this year., "Dr. DeBakey was one of ...
... , , SATURDAY, July 12 (HealthDay News) -- Summer is the ... is also the time for them to be most aware ... thunder roars, go indoors," Mary Ann Cooper, director of the ... Chicago, said in a prepared statement. "Decisions about lightning safety ...
... Emageon Inc.,(Nasdaq: EMAG ), a leader ... networks and imaging facilities,announced today that the Strategic ... Jefferies and Company as Lead Advisor and SunTrust,Robinson ... it evaluates all,strategic options available to the company., ...
... A,democratic process involving several SEIU local unions that began ... the best way to unite,long-term care workers in California ... their families and the clients they serve., "Today,s ... democratic,discussion to make sure that California long-term care workers ...
... million in cuts, WASHINGTON, July 11 Hundreds ... pay more out of pocket,for health care, while thousands ... approved this week by the U.S. Congress., The ... the,Medicare Advantage program over a five-year period, including cutting ...
Cached Medicine News:Health News:Are You Getting Burned by Your Sunscreen? 2Health News:Are You Getting Burned by Your Sunscreen? 3Health News:Summer Is Peak Time for Lightning Strikes 2Health News:Florida Seniors' Medicare Advantage Benefits at Risk 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: